by The global Biotechnology and Pharmaceutical Services Outsourcing market size is expected to be worth around US$ 105.4 billion by 2030, according to a new report by Vision Research Reports.
The global Biotechnology and Pharmaceutical Services Outsourcing market size was valued at US$ 63.1 billion in 2020 and is anticipated to grow at a CAGR of 6.8% during forecast period 2021 to 2030.
Download Exclusive Sample of Report@ https://www.visionresearchreports.com/report/sample/38968
Table of Contents
Biotechnology and Pharmaceutical Growth Factors
Rising pricing pressure, lack of internal capabilities, low-cost service offerings by CROs and CMOs, and access to industry experts are expected to drive the market over the forecast period. In addition, rising drug development costs, higher failure rates, and growing regulatory pressure have a significant impact on market dynamics, accelerating the growth rate. Furthermore, well-established Clinical Research Organizations (CROs), regulatory outsourcing firms, management consulting firms, and contract manufacturers are catering to the complex demand of the pharmaceutical and biotechnological sectors.
An increasing number of end-to-end service providers to meet the rising demand for low-cost drug development and manufacturing is further anticipated to propel the growth of the market. Moreover, novel drug delivery mechanisms and new product launches are anticipated to drive the outsourcing demand.
Biotechnology and Pharmaceutical Report Coverage
| Report Scope | Details |
| Market Size | US$ 5.78 billion by 2030 |
| Growth Rate | CAGR of 6.1% From 2021 to 2030 |
| Base Year | 2021 |
| Forecast Period | 2021 to 2030 |
| Segments Covered | Service, End-use |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
| Companies Mentioned | The Quantic Group; IQVIA; Parexel International Corporation; Lachman Consultant Services, Inc.; GMP Pharmaceuticals Pty Ltd.; Concept Heidelberg GmbH; Covance, Inc.; Charles River Laboratories; PRA Health Sciences; ICON plc |
By Service Analysis
Consulting services held the largest revenue share of over 16.0% in 2020. This can be attributed to the increasing MandA activities and constantly changing regulatory protocols.
The pharma and biotech market has witnessed the continuous entry of new players such as Signa Medical Writing; bioSyntagma; and Fieve Clinical Research, Inc. These players need to be compliant with set standards and norms, for which consulting is essential as these new entrants lack in such capabilities.
The other services segment is expected to expand at the highest CAGR over the forecast period owing to rising outsourcing of generics and biosimilar manufacturing as CMOs are offering services at a lower cost. The others segment is inclusive of contract manufacturing, product upgrade, and IT consulting.
By End-use Analysis
The pharma segment held the largest revenue share of over 55.0% in 2020 and is expected to maintain its lead throughout the forecast period. The segment is also expected to witness the fastest growth over the forecast period.
Lack of resources has prompted many pharmaceutical companies to outsource drug development and manufacturing of their products to CROs and CMOS. The CROs and CMOs offer highly sophisticated development and manufacturing services, such as preclinical development, clinical development, commercial manufacturing, clinical manufacturing.
By Regional Analysis
North America dominated the market with a revenue share of over 51.0% in 2020 owing to the presence of several established CROs and CMOs such as Covance Inc.; IQVIA; Catalent; and Samsung Biologics and growing RandD investments by life sciences and pharmaceutical companies in the region.
Asia Pacific is anticipated to witness the highest growth over the forecast period. Low cost of drug development and manufacturing and availability of skilled workforce is likely to foster contract development and manufacturing in this region.
Read also @ Healthcare ERP Market Opportunities & Forecast 2021-2030
Major Key Players Covered in The Biotechnology and Pharmaceutical Services Outsourcing Market Report include
- The Quantic Group
- IQVIA
- Parexel International Corporation
- Lachman Consultant Services, Inc.
- GMP Pharmaceuticals Pty Ltd.
- Concept Heidelberg GmbH
- Covance Inc.
- Charles River Laboratories
- PRA Health Sciences
- ICON plc
Biotechnology and Pharmaceutical Services Outsourcing Market Segmentation
- By Service
- Consulting
- Regulatory Compliance
- Remediation
- Quality Management Systems Consulting
- Others
- Auditing and Assessment
- Regulatory Affairs
- Clinical Trial Applications and Product Registration
- Regulatory Writing and Publishing
- Legal Representation
- Others
- Product Maintenance
- Product Design and Development
- Product Testing and Validation
- Training and Education
- Others
- Consulting
- By End-use
- Pharma
- Biotech
- Regional
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Italy
- Spain
- Asia Pacific
- India
- China
- Japan
- Australia
- South Korea
- Latin America
- Brazil
- Mexico
- Argentina
- Middle East and Africa
- South Africa
- Saudi Arabia
- UAE
- North America
Table of Contents
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Biotechnology and Pharmaceutical Services Outsourcing Market Snapshot
Chapter 4. Biotechnology and Pharmaceutical Services Outsourcing Market Variables and Scope
4.1. Introduction
4.2. Biotechnology and Pharmaceutical Services Outsourcing Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and End-use Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Biotechnology and Pharmaceutical Services Outsourcing Market Dynamics Analysis and Trends
5.1. Biotechnology and Pharmaceutical Services Outsourcing Market Dynamics
5.1.1. Biotechnology and Pharmaceutical Services Outsourcing Market Drivers
5.1.2. Biotechnology and Pharmaceutical Services Outsourcing Market Restraints
5.1.3. Biotechnology and Pharmaceutical Services Outsourcing Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Biotechnology and Pharmaceutical Services Outsourcing Market Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Biotechnology & Pharmaceutical Services Outsourcing Market, By Service
7.1. Biotechnology & Pharmaceutical Services Outsourcing Market, by Service, 2021-2030
7.1.1. Consulting
7.1.1.1. Market Revenue and Forecast (2017-2030)
7.1.2. Auditing and Assessment
7.1.2.1. Market Revenue and Forecast (2017-2030)
7.1.3. Regulatory Affairs
7.1.3.1. Market Revenue and Forecast (2017-2030)
7.1.4. Product Maintenance
7.1.4.1. Market Revenue and Forecast (2017-2030)
7.1.5. Product Design & Development
7.1.5.1. Market Revenue and Forecast (2017-2030)
7.1.6. Product Testing & Validation
7.1.6.1. Market Revenue and Forecast (2017-2030)
7.1.7. Training & Education
7.1.7.1. Market Revenue and Forecast (2017-2030)
Chapter 8. Global Biotechnology & Pharmaceutical Services Outsourcing Market, By End-use
8.1. Biotechnology & Pharmaceutical Services Outsourcing Market, by End-use, 2021-2030
8.1.1. Pharma
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Biotech
8.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Biotechnology & Pharmaceutical Services Outsourcing Market, Regional Estimates and Trend Forecast
9.1. North America
9.1.1. Market Revenue and Forecast, by Service (2017-2030)
9.1.2. Market Revenue and Forecast, by End-use (2017-2030)
9.1.3. U.S.
9.1.3.1. Market Revenue and Forecast, by Service (2017-2030)
9.1.3.2. Market Revenue and Forecast, by End-use (2017-2030)
9.1.4. Rest of North America
9.1.4.1. Market Revenue and Forecast, by Service (2017-2030)
9.1.4.2. Market Revenue and Forecast, by End-use (2017-2030)
9.2. Europe
9.2.1. Market Revenue and Forecast, by Service (2017-2030)
9.2.2. Market Revenue and Forecast, by End-use (2017-2030)
9.2.3. UK
9.2.3.1. Market Revenue and Forecast, by Service (2017-2030)
9.2.3.2. Market Revenue and Forecast, by End-use (2017-2030)
9.2.4. Germany
9.2.4.1. Market Revenue and Forecast, by Service (2017-2030)
9.2.4.2. Market Revenue and Forecast, by End-use (2017-2030)
9.2.5. France
9.2.5.1. Market Revenue and Forecast, by Service (2017-2030)
9.2.5.2. Market Revenue and Forecast, by End-use (2017-2030)
9.2.6. Rest of Europe
9.2.6.1. Market Revenue and Forecast, by Service (2017-2030)
9.2.6.2. Market Revenue and Forecast, by End-use (2017-2030)
9.3. APAC
9.3.1. Market Revenue and Forecast, by Service (2017-2030)
9.3.2. Market Revenue and Forecast, by End-use (2017-2030)
9.3.3. India
9.3.3.1. Market Revenue and Forecast, by Service (2017-2030)
9.3.3.2. Market Revenue and Forecast, by End-use (2017-2030)
9.3.4. China
9.3.4.1. Market Revenue and Forecast, by Service (2017-2030)
9.3.4.2. Market Revenue and Forecast, by End-use (2017-2030)
9.3.5. Japan
9.3.5.1. Market Revenue and Forecast, by Service (2017-2030)
9.3.5.2. Market Revenue and Forecast, by End-use (2017-2030)
9.3.6. Rest of APAC
9.3.6.1. Market Revenue and Forecast, by Service (2017-2030)
9.3.6.2. Market Revenue and Forecast, by End-use (2017-2030)
9.4. MEA
9.4.1. Market Revenue and Forecast, by Service (2017-2030)
9.4.2. Market Revenue and Forecast, by End-use (2017-2030)
9.4.3. GCC
9.4.3.1. Market Revenue and Forecast, by Service (2017-2030)
9.4.3.2. Market Revenue and Forecast, by End-use (2017-2030)
9.4.4. North Africa
9.4.4.1. Market Revenue and Forecast, by Service (2017-2030)
9.4.4.2. Market Revenue and Forecast, by End-use (2017-2030)
9.4.5. South Africa
9.4.5.1. Market Revenue and Forecast, by Service (2017-2030)
9.4.5.2. Market Revenue and Forecast, by End-use (2017-2030)
9.4.6. Rest of MEA
9.4.6.1. Market Revenue and Forecast, by Service (2017-2030)
9.4.6.2. Market Revenue and Forecast, by End-use (2017-2030)
9.5. Latin America
9.5.1. Market Revenue and Forecast, by Service (2017-2030)
9.5.2. Market Revenue and Forecast, by End-use (2017-2030)
9.5.3. Brazil
9.5.3.1. Market Revenue and Forecast, by Service (2017-2030)
9.5.3.2. Market Revenue and Forecast, by End-use (2017-2030)
9.5.4. Rest of LATAM
9.5.4.1. Market Revenue and Forecast, by Service (2017-2030)
9.5.4.2. Market Revenue and Forecast, by End-use (2017-2030)
Chapter 10. Company Profiles
10.1. The Quantic Group
10.1.1. Company Overview
10.1.2. Service Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. IQVIA
10.2.1. Company Overview
10.2.2. Service Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Parexel International Corporation
10.3.1. Company Overview
10.3.2. Service Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. Lachman Consultant Services, Inc.
10.4.1. Company Overview
10.4.2. Service Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. GMP Pharmaceuticals Pty Ltd.
10.5.1. Company Overview
10.5.2. Service Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. Concept Heidelberg GmbH
10.6.1. Company Overview
10.6.2. Service Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. Covance Inc.
10.7.1. Company Overview
10.7.2. Service Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. Richard Wolf GmbH
10.8.1. Company Overview
10.8.2. Service Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9. Charles River Laboratories
10.9.1. Company Overview
10.9.2. Service Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
10.10. PRA Health Sciences
10.10.1. Company Overview
10.10.2. Service Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives
Chapter 11. Research Methodology
11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions
Chapter 12. Appendix
12.1. About Us
12.2. Glossary of Terms
Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38968
Contact Us:
Vision Research Reports
Call: +1 9197 992 333
